Concepedia

Chisato Kamimaki

CK

Statistics

Publications

5

Citations

78

H-Index

5

Active since

2020

Affiliations

Yokohama City University Medical Center(Current)

Yokohama City University

Yanbian University

Yanbian University Hospital

Chisato Kamimaki is an author at Yokohama City University Medical Center specializing in molecular diagnostics, immunology, and tuberculosis.

ORCID

Top concepts

Publications per year

2020–2021

5

Publications

5

<scp>MicroRNA</scp>‐200b is a potential biomarker of the expression of <scp>PD‐L1</scp> in patients with lung cancer

Seigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto et al. · Thoracic Cancer · 2020 · 20 citations · Full text

Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor

Sousuke Kubo, Nobuaki Kobayashi, Kohei Somekawa et al. · Anticancer Research · 2020 · 17 citations · Full text

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial

Hiromi Matsumoto, Nobuaki Kobayashi, Kohei Somekawa et al. · Thoracic Cancer · 2021 · 16 citations · Full text

Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan

Seigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto et al. · Tuberculosis · 2020 · 15 citations

, , +9

T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

Chisato Kamimaki, Nobuaki Kobayashi, Momo Hirata et al. · Thoracic Cancer · 2021 · 10 citations · Full text

1–5 of 5